लोड हो रहा है...
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Although the clinical development of immune checkpoint inhibitors (ICIs) therapy has ushered in a new era of anti-tumor therapy, with sustained responses and significant survival advantages observed in multiple tumors, most patients do not benefit. Therefore, more and more attention has been paid to...
में बचाया:
| में प्रकाशित: | Biomark Res |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7450548/ https://ncbi.nlm.nih.gov/pubmed/32864131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00209-0 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|